Skip to Content

Australian Investment Blog

Afternoon Report 25/01/2019

Equities finish the week higher

WHAT MATTERED TODAY

The market rallied today, following on from yesterday’s 20 point grind higher to add another ~40 points today. Buying was seen across the board with banks, resources, tech & even the retail names getting in on the act. Franking credit talk helped those with large balances, commodity prices pushed higher and the US futures helped pull the local market higher. Healthcare the only sector to finish in the red, stemming from a disappointing report from ResMed which we discuss later. Iluka (ASX: ILU) was the best performer today after a solid 4th quarter production, but more importantly Zircon and Ti2O prices moving higher with the CEO calling for the rally to continue.

Overall, the index closed up 39 points or +0.68% today to 5905 and was up 0.44% on the week. Dow Futures are trading up 120 points / 0.49%.

ASX 200 Chart

ASX 200 Chart

CATCHING OUR EYE

Broker Moves;

· Platinum Asset Rated New Sell at Citi; PT A$4.20

· Pendal Group Rated New Neutral at Citi; PT A$8.20

· Magellan Financial Rated New Buy at Citi; PT A$31

· Suncorp Upgraded to Buy at Citi; PT A$14.60

· Santos Upgraded to Buy at UBS; PT A$7.20

· OceanaGold Cut to Neutral at PI Financial; Price Target C$5

· Qantas Downgraded to Neutral at Credit Suisse; PT A$6.70

· Galaxy Resources Raised to Outperform at Credit Suisse

· Sydney Airport Raised to Overweight at Morgan Stanley; PT A$7.07

· Australian Pharma Cut to Underweight at Morgan Stanley

· South32 Downgraded to Neutral at Exane

· Orora Downgraded to Underweight at Morgan Stanley

Sectors this week;

Stocks this week;

Some of the specific events we covered during the week…

ResMed (ASX: RMD) misses 2nd quarter revenue target; the stock was smashed today after falling short of analysts’ expectations. Click here

Sims Metals (ASX: SGM) started the week poorly with a profit downgrade; the scrap metal name did rally back today, but was smashed to long term lows on Monday. Click here

Challenger (ASX: CGF) shares challenged on poor guidance; the share price tracked lower this week driven by lowered profit growth guidance. Click here

5 stocks that didn’t join the rally, are they worth a look?; will these 5 stocks join the market rebound? Click here

Quarterly production figures drove news flow; read BHP here

OUR CALLS

No changes the portfolios today.

Watch out for the weekend report. Have a great night,

James / Harry & the Market Matters Team

Disclosure

Market Matters may hold stocks mentioned in this report. Subscribers can view a full list of holdings on the website by clicking here. Positions are updated each Friday, or after the session when positions are traded.

Disclaimer

All figures contained from sources believed to be accurate. Market Matters does not make any representation of warranty as to the accuracy of the figures and disclaims any liability resulting from any inaccuracy. Prices as at 25/01/2019

Reports and other documents published on this website and email (‘Reports’) are authored by Market Matters and the reports represent the views of Market Matters. The MarketMatters Report is based on technical analysis of companies, commodities and the market in general. Technical analysis focuses on interpreting charts and other data to determine what the market sentiment about a particular financial product is, or will be. Unlike fundamental analysis, it does not involve a detailed review of the company’s financial position.

The Reports contain general, as opposed to personal, advice. That means they are prepared for multiple distributions without consideration of your investment objectives, financial situation and needs (‘Personal Circumstances’). Accordingly, any advice given is not a recommendation that a particular course of action is suitable for you and the advice is therefore not to be acted on as investment advice. You must assess whether or not any advice is appropriate for your Personal Circumstances before making any investment decisions. You can either make this assessment yourself, or if you require a personal recommendation, you can seek the assistance of a financial advisor. Market Matters or its author(s) accepts no responsibility for any losses or damages resulting from decisions made from or because of information within this publication. Investing and trading in financial products are always risky, so you should do your own research before buying or selling a financial product.

The Reports are published by Market Matters in good faith based on the facts known to it at the time of their preparation and do not purport to contain all relevant information with respect to the financial products to which they relate. Although the Reports are based on information obtained from sources believed to be reliable, Market Matters does not make any representation or warranty that they are accurate, complete or up to date and Market Matters accepts no obligation to correct or update the information or opinions in the Reports. Market Matters may publish content sourced from external content providers.

If you rely on a Report, you do so at your own risk. Past performance is not an indication of future performance. Any projections are estimates only and may not be realised in the future. Except to the extent that liability under any law cannot be excluded, Market Matters disclaims liability for all loss or damage arising as a result of any opinion, advice, recommendation, representation or information expressly or impliedly published in or in relation to this report notwithstanding any error or omission including negligence.

image description

Relevant suggested news and content from the site

Back to top